Shaili Tapiavala, MD joined the Division of Hospital Medicine in the Department of Internal Medicine as an Instructor in July of 2025. She was born in New York and soon moved to Dallas, Texas. She attended the University of Miami with merit scholarship and graduated with a bachelor’s degree in biology and public health and a minor in chemistry. She subsequently received her medical degree from Texas A&M College of Medicine in 2022. Tapiavala completed her internship and residency at Barnes-Jewish Hospital/WashU School of Medicine in St. Louis prior to joining the division in 2025. In addition to her clinical skills and research work, Tapiavala developed a strong interest in medical education and further enhanced her leadership abilities by completed the Forum for Women in Medicine Leadership Development Program. Her current areas of interest focus on health equity in oncologic care and treatment-related toxicity and its implications for patient morbidity.
Education
- BS, Biology and Public Health: University of Miami, Miami, FL (2017)
- MD: Texas A&M College of Medicine, College Station, TX (2022)
- Residency, Internal Medicine: Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO (2025)
Clinical Interests
Addressing health inequities in access, evaluation, and outcomes in oncologic care, breast cancer tumorigenesis, treatment-related toxicities
Publications
Tapiavala S, Preston A, Parekh P. Erythematous Nodule on the Upper Back: Answer. Am J
Dermatopathol. 2022;44(3):232-233. doi:10.1097/DAD.0000000000002121
Tapiavala S, Preston A, Parekh P. Erythematous Nodule on the Upper Back: Challenge. Am J
Dermatopathol. 2022;44(3):e28. doi:10.1097/DAD.0000000000002122
Abstracts
Podany E, Tapiavala S, Glover-Collins K, Linnenbringer E, Ballard S, Blair H, Ahmad T, Cyr A,
Thaier M, McDowell J, Golden A, Addison S, McFarland E, Hall L, Ademuyiwa F, Colditz G,
Eberlein T, Drake B, Bennett D, Weilbacher K. Hereditary cancer risk assessment and referral at highvolume, diverse mammography clinic. San Antonio Breast Cancer Symposium; December 12th, 2024. SESS-1021
Gerratana L, Davis A, Foffano L, Reduzzi C, Podany E, Medford A, Velimirovic M, Clifton K, Putur
A, Munoz-Arcos L, Pontolillo L, Abelman R, Gianni C, Tapiavala S, Molteni E, Lipsyc-Sharf M,
Nicolò E, Andreopoulou E, Gradishar W, Puglisi F, Ma C, Bardia A, Cristofanilli M. Differential
ctDNA-based genomic features of Triple-Negative Metastatic Lobular Breast carcinoma: insights into a rare and poorly understood disease. San Antonio Breast Cancer Symposium; December 11th, 2024. SESS-2085
Tapiavala S, Roy S, Hensing W, Liu Y, Ademuyima F, Cyr A. Impact of American Society of Breast Surgeons (ASBS) guidelines on genetic testing (GT) rates among patients with breast cancer (BC). 2024 American Society of Clinical Oncology; May 31st, 2024. Abstract e22537
Tapiavala S, Shenouda M, Patel V, Davis A. Reporting of immune-related adverse events (irAEs) in US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors. American Society of Clinical Oncology; May 31st, 2024. Abstract e14693.
Podany E, Foffano L, Gerratana L, Medford A, Clifton K, Tapiavala S, Velimirovic M, Lipsync-Sharf M, Shah A, Reduzzi C, Munoz-Arcos L, Putur A, Ademuyima F, Puglisi F, Ma C, Bardia A,
Cristofanilli M, Davis A. Racial differences in genomic profiles and targeted treatment use in ER+HER2- metastatic breast cancer. American Society of Clinical Oncology; May 31st, 2024. Abstract 1017.
Gerratana L, Davis A, Foffano L, Reduzzi C, Podany E, Medford A, Clifton K, Velimirovic M, Putur
A, Munoz-Arcos L, Pontolillo L, Tapiavala S, Molteni E, Nicolò E, Gradishar W, Ma C,
Andreopoulou E, Puglisis F, Bardia A, Cristofanilli M. Differential genomic profiling of the
progesterone receptor (PR) negative and estrogen receptor (ER) low metastatic breast cancer subtypes through circulating tumor DNA: A TNBC-like disease. American Society of Clinical Oncology; May 31st, 2024. Abstract 1039.
Tapiavala, S. (July 2019). “The Role of a Western Diet in Regulating Expression of Farnesoid X
Receptor and Colorectal Cancer Progression. Proceedings of the Texas A&M Medical Student Grand Rounds.